SCHEMBL1662030

SCHEMBL1662030

C=CC(=O)OCCOC1CC2CC1C1C2CC2OC21

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.36
ALDH1A1 P00352 3/20 0.36
TP53 P04637 2/20 0.36
HIF1A Q16665 2/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.31
THRB P10828 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1659030 0.90 TSHR (0.36) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL12808964 0.82 THRB (0.35) TSHRALDH1A1THRB
SCHEMBL274389 0.82
SCHEMBL16378493 0.81 TSHR (0.34) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL14493235 0.79 TSHR (0.37) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL16271868 0.79 TSHR (0.32) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL12909359 0.79
SCHEMBL25549302 0.79
SCHEMBL14302996 0.77 TSHR (0.40) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL10085528 0.77 TSHR (0.40) TSHRALDH1A1TP53HIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230367049-A1 COLORED COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-11-16 US disclosed
US-20230312869-A1 COLORED RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-05 US disclosed
US-11693310-B2 Blue curable resin composition, blue color filter, and display device including same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-04 US disclosed
US-20230130507-A1 NEGATIVE RESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US disclosed
WO-2014208767-A1 COLORED CURABLE RESIN COMPOSITION 住友化学株式会社 (JP) 2014-12-31 WO disclosed
WO-2014192973-A1 COMPOUND AND COLORED CURABLE RESIN COMPOSITION 住友化学株式会社 (JP) 2014-12-04 WO disclosed
US-8084545-B2 Photo- and/or thermo-curable copolymer, curable resin compositions, and cured articles DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2011-12-27 US disclosed
US-20110112266-A1 CURABLE COPOLYMER AND CURABLE RESIN COMPOSITION DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2011-05-12 US disclosed
EP-2308905-A1 CURABLE COPOLYMER AND CURABLE RESIN COMPOSITION Daicel Chemical Industries, Ltd. (JP) 2011-04-13 EP disclosed
WO-2011018987-A1 DISPLAY DEVICE 住友化学株式会社 (JP) 2011-02-17 WO disclosed
US-20100137515-A1 PHOTO- AND/OR THERMO-CURABLE COPOLYMER, CURABLE RESIN COMPOSITIONS, AND CURED ARTICLES DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-03 US disclosed
EP-2147937-A1 PHOTO- AND/OR THERMO-CURABLE COPOLYMER, CURABLE RESIN COMPOSITIONS, AND CURED ARTICLES Daicel Chemical Industries, Ltd. (JP) 2010-01-27 EP disclosed
US-20090124776-A1 Cycloaliphatic epoxy (meth)acrylates, preparation processes thereof, and copolymers DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2009-05-14 US disclosed
EP-1818327-A1 ALICYCLIC EPOXY (METH)ACRYLATES, PROCESS FOR PRODUCTION THEREOF, AND COPOLYMERS Daicel Chemical Industries, Ltd. (JP) 2007-08-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124776-A1 Cycloaliphatic epoxy (meth)acrylates, preparation processes thereof, and copolymers MEP1B, MEP1A, ACMSD TSHR 3947/4885ALDH1A1 1902/4885TP53 4821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.